| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/29/2004 | WO2004035093A2 Polymeric materials for site specific delivery to the body |
| 04/29/2004 | WO2004035071A1 Herbal medicine containing cyclodextrins for the treatment of ear disorders |
| 04/29/2004 | WO2004035052A1 Stable solid preparations |
| 04/29/2004 | WO2004035044A1 Dry syrup preparation of procaterol comprising ascorbinic acid and citric acid |
| 04/29/2004 | WO2004035028A1 Method for producing the microcapsulated form of a live viral vaccine |
| 04/29/2004 | WO2004035027A1 Pharmaceutical formulation of olanzapine |
| 04/29/2004 | WO2004035022A2 Prepolymeric materials for site specific delivery to the body |
| 04/29/2004 | WO2004035006A2 Methods and compositions for immunization against hiv |
| 04/29/2004 | WO2004034975A2 Sustained release profile modification |
| 04/29/2004 | WO2004034967A2 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety |
| 04/29/2004 | WO2004017914A3 Inhalation composition |
| 04/29/2004 | WO2004005470A3 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 04/29/2004 | WO2004000016A3 Antimicrobial compositions, products and methods employing same |
| 04/29/2004 | WO2003104282A8 Glycoprotein vi - fc fusion protein for treating vascular disorders |
| 04/29/2004 | WO2003103723A3 Neutrophil imaging methods in cyctic fibrosis |
| 04/29/2004 | WO2003086369A3 Stealthy polymeric biodegradable nanospheres and uses thereof |
| 04/29/2004 | WO2003086267B1 Multi-phase, multi-compartment capsular system |
| 04/29/2004 | WO2003086172A3 Method for tagging colonic residue |
| 04/29/2004 | WO2003064496A9 Biodegradable polymer |
| 04/29/2004 | WO2003053473A3 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 04/29/2004 | WO2003032913A9 Methods and compositions for targeting proteins across the blood brain barrier |
| 04/29/2004 | WO2003028667A9 Semisolid topical hormonal compositions and methods for treatment |
| 04/29/2004 | WO2003020949A3 Targeted nucleic acid constructs and uses related thereto |
| 04/29/2004 | WO2003015612A9 Materials and methods to promote repair of nerve tissue |
| 04/29/2004 | WO2003012039A8 Targeting nucleic acids to a cellular nucleus |
| 04/29/2004 | WO2003004517A3 Peyers's patch and/or m-celle targeting ligands |
| 04/29/2004 | WO2002102391A3 Composition comprising nanoparticulate spironolactone |
| 04/29/2004 | WO2002066056A8 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 04/29/2004 | WO2002066009A8 Modulated release particles for aerosol delivery |
| 04/29/2004 | WO2002055089A9 Immunoassay technique using multispecific molecules |
| 04/29/2004 | WO2002043771A9 Conjugates of glycosylated/galactosylated peptide |
| 04/29/2004 | WO2002032941A8 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 04/29/2004 | WO2001095899A8 Pharmaceutical compositions comprising cannabidiol derivatives |
| 04/29/2004 | US20040083497 Genetic engineering; induct immunology response using antibodies |
| 04/29/2004 | US20040082936 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 04/29/2004 | US20040082934 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 04/29/2004 | US20040082777 Process for producing aqueous cellulose derivative dispersions |
| 04/29/2004 | US20040082765 Immobilization; sustained release |
| 04/29/2004 | US20040082764 Complex of antibodic and antibiotic with carrier |
| 04/29/2004 | US20040082716 Hydrogel attached to backing and method for making same |
| 04/29/2004 | US20040082660 Using latanoprost |
| 04/29/2004 | US20040082649 Bioavailability; prevent damage to cell membranes, cardiovascular disorders; vision defects; skin diosrders; anticholesterol agents; antitumor agents |
| 04/29/2004 | US20040082634 Using allantoin; skin disorders, antiulcer agents, antiinflammatory agents |
| 04/29/2004 | US20040082600 Bioavailability; oral administering; cardiovascular disorders; sexual disorders |
| 04/29/2004 | US20040082593 Mixing with aqueous solution containing sulfuric acid or sodium bisulfate; stabilization |
| 04/29/2004 | US20040082545 Transferring sodium hydroxide solution to container; osteoporosis, antitumor agents |
| 04/29/2004 | US20040082524 Use of aivlosin, 3-O-acetyl-4''-O-isovaleryl-tylosin and pharmacologically acceptable derivatives; treatment of necrotic enteritis in poultry and Lawsonia infections, Mycoplasma diseases and swine dysentery in pigs |
| 04/29/2004 | US20040082523 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
| 04/29/2004 | US20040082520 Comprising an alkyl-polyglycoside surfactant and a medicament for inhalation |
| 04/29/2004 | US20040082501 Compounds and method for the prevention and treatment of diabetic retinopathy |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | US20040082067 Immunology, diagnosis, therapy; complex of carbohydrate and protein; immobilization |
| 04/29/2004 | US20040081984 Ocular tear growth factor-like protein |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081715 Cholesterol reducing confectionery comprising a cocoa procyanidin monomer and/or oligomer and a sterol and/or stanol based cholesterol lowering agent |
| 04/29/2004 | US20040081707 Tetraglycol as a solvent for molecular iodine in the preparation of a topical counter-irritant against skin burns |
| 04/29/2004 | US20040081699 Quickly disintegrate in aqueous media |
| 04/29/2004 | US20040081696 Irradiation directly transfers the energy required to evaporate the solvent to the drug coated particle |
| 04/29/2004 | US20040081694 Melt-extruded orally administrable opioid formulations |
| 04/29/2004 | US20040081693 Capable of releasing the drug at a constant rate following zero order kinetics for 24 hours or more |
| 04/29/2004 | US20040081688 Comprising a drug, a lipid matrix and a surfactant characterized in that said drug is a peptide or a protein and lipid matrix has a monoglyceride content which is at least 70% w/w |
| 04/29/2004 | US20040081686 Use of particle vectors in immunomodulation |
| 04/29/2004 | US20040081685 Plurality of patch units connected along one or more borders divisible into respective units allowing dosage to be adjusted |
| 04/29/2004 | US20040081684 Topical delivery of antifungal agents |
| 04/29/2004 | US20040081682 Crystal-free transdermal formulations of the more active (-)-enantiomer of rolipram that are easy to administer |
| 04/29/2004 | US20040081681 Anhydrous formulations for percutaneous absorption |
| 04/29/2004 | US20040081677 Gel formulations of hydroxypyridone derivatives, which contain solvents and hydrophilic gel-forming agents make possible a high release of the active compound |
| 04/29/2004 | US20040081674 For the treatment of dry, sensitive skin. Despite being free from such ingredients as perfumes, preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohol, lower alcohols and proteins |
| 04/29/2004 | US20040081670 Method for producing an active ingredient concentrate, and an active ingredient concentrate |
| 04/29/2004 | US20040081660 Polypeptide and protein derivatives and process for their preparation |
| 04/29/2004 | US20040081659 Conjugates useful in the treatment of prostate cancer |
| 04/29/2004 | US20040081655 Methods and compositions comprising polycationic compounds |
| 04/29/2004 | US20040081653 Aberrantly over-expressed in at least some cancers, such as prostate and bladder cancers |
| 04/29/2004 | US20040081648 Adzymes and uses thereof |
| 04/29/2004 | US20040081647 For inhibiting receptor-mediated signaling activity of an extracellular substrate polypeptide |
| 04/29/2004 | US20040081645 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/29/2004 | US20040081624 Mixture containing high volatility carrier; vaporization; mixing with air |
| 04/29/2004 | DE10296849T5 Verfahren zur Einkapselung eines Wirkstoffes A process for encapsulation of an active ingredient |
| 04/29/2004 | CA2783175A1 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 04/29/2004 | CA2771725A1 Solid preparation comprising a non-toxic base and a proton pump inhibitor |
| 04/29/2004 | CA2502367A1 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 04/29/2004 | CA2502218A1 Composition with stabilized redox properties and method of stabilization of redox properties |
| 04/29/2004 | CA2502211A1 Azo compounds for type i phototherapy |
| 04/29/2004 | CA2501990A1 Cationic cardiolipin analogs and use thereof |
| 04/29/2004 | CA2501298A1 Method of modifying the release profile of sustained release compositions |
| 04/29/2004 | CA2497313A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 04/28/2004 | EP1413331A2 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) for vascular indications |
| 04/28/2004 | EP1413312A2 Therapeutic human albumin having a low aluminium binding activity |
| 04/28/2004 | EP1413311A1 Compositions for nasal administration of insulin |
| 04/28/2004 | EP1413310A1 Sustained-release compositions for injection and process for producing the same |
| 04/28/2004 | EP1413297A1 Cyclosporin-containing soft capsule preparations |
| 04/28/2004 | EP1413295A1 Sustained release composition for oral administration of drugs |
| 04/28/2004 | EP1413294A1 COMPOSITIONS CONTAINING SUSTAINED−RELEASE FINE GRAINS FOR TABLETS QUICKLY DISINTEGRABLE IN THE ORAL CAVITY AND PROCESS FOR PRODUCING THE SAME |
| 04/28/2004 | EP1413292A1 Bioadhesive pharmaceutical compositions based on non-steroidal anti-inflammatory drugs |
| 04/28/2004 | EP1413201A2 Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals |
| 04/28/2004 | EP1412750A2 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 04/28/2004 | EP1412462A1 Lanolin substitute, production method thereof and applications of same |
| 04/28/2004 | EP1412424A1 Improvements in or relating to modified cellulose films |
| 04/28/2004 | EP1412391A1 Chitosan preparation |
| 04/28/2004 | EP1412389A1 Binding agents with differential activity |